Niacin-Cholic Acid-Peptide Conjugate Act as a Potential Antibiotic Adjuvant to Mitigate Polymicrobial Infections Caused by Gram-Negative Pathogens
- 20 November 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (12) , 4146-4155
Abstract
Polymicrobial wound infections caused by Gram-negative bacteria and associated inflammation are challenging to manage, as many antibiotics do not work against these infections. Utilizing adjuvants to repurpose the existing antibiotics for mitigating microbial infections presents an alternative therapeutic strategy. We designed and developed a niacin-cholic acid-peptide conjugate (1) to rejuvenate the therapeutic efficacy of macrolide antibiotics against Gram-negative pathogens. We conjugated niacin with anti-inflammatory properties at the carboxyl terminal of the cholic acid and dipeptide (glycine-valine) at the three hydroxyl terminals of cholic acid to obtain the amphiphile 1. Our findings demonstrated that amphiphile 1 serves as a microbial membrane disruptor that facilitates the entry of erythromycin (ERY) in bacterial cells. The combination of amphiphile 1 and ERY is bactericidal and can effectively eliminate monomicrobial and polymicrobial Gram-negative bacterial biofilms. We further demonstrated the antibacterial effectiveness of combining 1 and ERY against monomicrobial and polymicrobial wound infections. Together, these findings indicate that amphiphile 1 revitalizes the remedial efficacy of ERY against Gram-negative bacteria.Keywords
Funding Information
- Indian Council of Medical Research (Myco/fell/11/2022-ECD-II)
- Department of Biotechnology, Ministry of Science and Technology, India (BT/PR46214/MED/29/1624/2022)
This publication has 39 references indexed in Scilit:
- Dimeric Cholic Acid Peptide Conjugates Act as Effective Antibiotic Adjuvants against Multidrug Resistance (MDR) Gram‐Negative Bacterial InfectionsAdvanced Therapeutics, 2023
- Targeting Vancomycin-ResistantEnterococci(VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid–Peptide ConjugatesJournal of Medicinal Chemistry, 2022
- Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphilesMolecular Aspects of Medicine, 2021
- Recent Progress in Bile Acid-Based AntimicrobialsBioconjugate Chemistry, 2021
- Biofilms in Chronic Wounds: Pathogenesis and DiagnosisTrends in Biotechnology, 2019
- Deciphering the Role of Intramolecular Networking in Cholic Acid–Peptide Conjugates on the Lipopolysaccharide Surface in Combating Gram-Negative Bacterial InfectionsJournal of Medicinal Chemistry, 2019
- Oral Delivery of Cholic Acid-Derived Amphiphile Helps in Combating Salmonella-Mediated Gut Infection and InflammationBioconjugate Chemistry, 2019
- Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial InfectionsJournal of Medicinal Chemistry, 2018
- How Macrolide Antibiotics WorkTrends in Biochemical Sciences, 2018
- Cytokines and chemokines: At the crossroads of cell signalling and inflammatory diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014